Version 5.4
Homo sapiens Protein: NKAIN2
Summary
InnateDB Protein IDBP-96087.7
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol NKAIN2
Protein Name Na+/K+ transporting ATPase interacting 2
Synonyms
Species Homo sapiens
Ensembl Protein ENSP00000357401
InnateDB Gene IDBG-96083 (NKAIN2)
Protein Structure
UniProt Annotation
Function
Subcellular Localization Cell membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.
Disease Associations Note=A chromosomal aberration involving NKAIN2 is a cause of lymphoma. Deletion del(6)(q13q21) within NKAIN2 and involving SUSP1 generates the SUSP1-NKAIN2 product.
Tissue Specificity Expressed in fetal brain. Weakly expressed in adult brain and thymus. Not expressed in any other normal tissue examined. {ECO:0000269PubMed:11979551}.
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
Gene Ontology

Molecular Function
Accession GO Term
Biological Process
Cellular Component
GO:0005886 plasma membrane
GO:0016021 integral component of membrane
Protein Structure and Domains
PDB ID
InterPro IPR008516 Na,K-Atpase Interacting protein
PFAM PF05640
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt Q5VXU1
PhosphoSite PhosphoSite-
TrEMBL
UniProt Splice Variant
Entrez Gene 154215
UniGene Hs.656604
RefSeq
HUGO HGNC:16443
OMIM 609758
CCDS
HPRD 18168
IMGT
EMBL AB070452 AL121968 AL136224 AL354936 AL356605 BC035062
GenPept AAH35062 BAB85477 CAH73091 CAH73092 CAH73593 CAH73594 CAI19752 CAI19753 CAI20108

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca